Parhofer Klaus G
Medical Department II - Grosshadern, University Munich, Marchioninistraße 15, 81377 Munich, Germany.
Atheroscler Suppl. 2015 May;18:109-11. doi: 10.1016/j.atherosclerosissup.2015.02.020.
The relationship between atherosclerosis and HDL is more complex than between LDL and atherosclerosis. Low HDL-cholesterol is associated with atherosclerotic disease not in a causal way but because low HDL-cholesterol reflects an increased concentration of triglyceride-rich lipoproteins. At the same time the functionality of the HDL system plays an important role in atherosclerosis prevention (for example by mediating reverse cholesterol transport). However, these two observations are not directly linked to each other. Therefore therapeutic strategies must either aim at decreasing the concentration of triglyceride-rich lipoproteins (and thereby increase HDL-cholesterol concentration) or at improving HDL function (which may or may not affect HDL-cholesterol concentration). Simply increasing HDL-cholesterol concentration without improving function or decreasing triglyceride-rich lipoproteins will not be beneficial with respect to atherosclerosis prevention.
动脉粥样硬化与高密度脂蛋白(HDL)之间的关系比低密度脂蛋白(LDL)与动脉粥样硬化之间的关系更为复杂。低HDL胆固醇与动脉粥样硬化疾病相关,并非因果关系,而是因为低HDL胆固醇反映了富含甘油三酯的脂蛋白浓度增加。同时,HDL系统的功能在预防动脉粥样硬化中起着重要作用(例如通过介导胆固醇逆向转运)。然而,这两个观察结果并非直接相互关联。因此,治疗策略必须要么旨在降低富含甘油三酯的脂蛋白浓度(从而提高HDL胆固醇浓度),要么旨在改善HDL功能(这可能会或可能不会影响HDL胆固醇浓度)。单纯提高HDL胆固醇浓度而不改善功能或降低富含甘油三酯的脂蛋白,对于预防动脉粥样硬化并无益处。